Medicines (Export Licence for Psychotropic Substances) (Amendment) Regulations 2023

Status:

Published in Subsidiary Legislation Supplement
on 25 Oct 2023

No. S 683

Medicines Act 1975

Medicines (Export Licence for
Psychotropic Substances)
(Amendment) Regulations 2023

In exercise of the powers conferred by section 74 of the Medicines Act 1975, the Minister for Health makes the following Regulations:

Citation and commencement

1. These Regulations are the Medicines (Export Licence for Psychotropic Substances) (Amendment) Regulations 2023 and come into operation on 1 November 2023.

Amendment of Schedule

2. In the Medicines (Export Licence for Psychotropic Substances) Regulations (Rg 9), in the Schedule —

(a)

in paragraph 1, after the item “Alprazolam”, insert —

“Amineptine”;

(b)

in paragraph 1, after the item “Clonazepam”, insert —

“Clonazolam”;

(c)

in paragraph 1, after the item “Diazepam”, insert —

“Diclazepam”;

(d)

in paragraph 1, after the item “Etilamfetamine”, insert —

“Etizolam”;

(e)

in paragraph 1, after the item “Fenproporex”, insert —

“Flualprazolam

Flubromazolam”; and

(f)

replace paragraph 2 with —

“2. The stereoisomeric forms or salts of the substances specified in paragraph 1, wherever the existence of such stereoisomeric forms or salts is possible.”.

[G.N. Nos. S 417/2005; S 488/2005; S 543/2016; S 228/2017; S 98/2019; S 459/2022]

Made on 16 October 2023.

CHAN YENG KIT

Permanent Secretary,
Ministry of Health,
Singapore.

[401:04/03-000; AG/LEGIS/SL/176/2020/7 Vol. 1]

Search within Legislation